- Filed
- Nov 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Nov 1, 2025 | 20.49M sh |
| Shares Diluted | Q1 2026 · Sep 30, 2025 | 17.53M sh |
| Shares Diluted | Q1 2026 · Sep 30, 2024 | 14.12M sh |
| Operating Cash Flow | Q1 2026 · Sep 30, 2025 | −$13.8M |
| Operating Cash Flow restated | Q1 2026 · Sep 30, 2024 | −$4.15M |
| Cash And Equivalents | Q1 2026 · Sep 30, 2025 | $39.56M |
| Cash And Equivalents | Q1 2026 · Jun 30, 2025 | $39.44M |
| Stockholders Equity | Q1 2026 · Sep 30, 2025 | $295.15M |
| Stockholders Equity | Q1 2026 · Jun 30, 2025 | $287.72M |
| Current Liabilities | Q1 2026 · Sep 30, 2025 | $50.32M |
| Current Liabilities | Q1 2026 · Jun 30, 2025 | $36.61M |
| Total Liabilities | Q1 2026 · Sep 30, 2025 | $68.8M |
| Total Liabilities | Q1 2026 · Jun 30, 2025 | $57.01M |
| Current Assets | Q1 2026 · Sep 30, 2025 | $46.46M |
| Current Assets | Q1 2026 · Jun 30, 2025 | $56.7M |
| Total Assets | Q1 2026 · Sep 30, 2025 | $484.16M |
| Total Assets | Q1 2026 · Jun 30, 2025 | $446.46M |
| Eps Diluted | Q1 2026 · Sep 30, 2025 | −$0.47 |
| Eps Diluted | Q1 2026 · Sep 30, 2024 | −$0.42 |
| Eps Basic | Q1 2026 · Sep 30, 2025 | −$0.47 |
| Eps Basic | Q1 2026 · Sep 30, 2024 | −$0.42 |
| Sga Expense | Q1 2026 · Sep 30, 2025 | $1.6M |
| Sga Expense restated | Q1 2026 · Sep 30, 2024 | $1.41M |
| Rd Expense | Q1 2026 · Sep 30, 2025 | $191K |
| Rd Expense | Q1 2026 · Sep 30, 2024 | $0 |
| Net Income | Q1 2026 · Sep 30, 2025 | −$8.18M |
| Net Income restated | Q1 2026 · Sep 30, 2024 | −$5.9M |
| Operating Income | Q1 2026 · Sep 30, 2025 | −$8.21M |
| Operating Income restated | Q1 2026 · Sep 30, 2024 | −$6.98M |
| Revenue | Q1 2026 · Sep 30, 2025 | $0 |
| Revenue | Q1 2026 · Sep 30, 2024 | $0 |